Login

Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck 00:00:00

Share On Facebook Share On Twitter

Hemcheck | CEO interview, Joen Averstad, CEO, Hemcheck

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Bridgewater Associates’ Greg Jensen Discusses Market Opportunities, Trump Policies, Political Risks, and AI-Driven Fund Launch on Bloomberg Open Interest
00:10:00
CEO discusses plans to transition to a true corporation, focusing on decarbonization, ESG initiatives, and ambitious growth targets | Daniel Pimentel Slaviero, CEO, Companhia Paranaense de Energia.
00:00:00
Kidney Health Testing for People With Diabetes - Dr. Joseph Vassalotti, Chief Medical Officer
00:10:00
Revolutionizing Mining Operations: A Deep Dive into Mine Vision Systems | Mike Smocer, CEO of Mine Vision Systems
00:10:00
The REIT is listed on the Singapore stock exchange and focuses in Industrial & logistic properties in Singapore and Australia|CEO,AIMS APAC REIT
00:10:00
Milan Patel, CEO of Dotdigital, highlights the significant growth driven by new and existing customers, with SMS channels playing a crucial role​|Milan Patel, CEO of Dotdigital
00:10:00
State Bank of India Chairman Discusses India's Banking Resilience and Global Influence | Dinesh Kumar Khara, Chairman , State Bank of India.
00:00:00
Promise of Editing Point Mutations - David R. Liu Thomas Dudley Cabot Professor of the Natural Sciences Howard Hughes Medical Institute Investigator
00:10:00
Base Resources: Leveraging Success in Mineral Sands Production and Expansion
00:10:00
Michael Granoff on Global Financial Trends and India's Economic Progress
00:10:00
The Owner’s Mentality: Insights from Greg Padilla, Portfolio Manager at Aristotle Capital
00:10:00
Emmanuel Roman Discusses Pimco's Strategy and Market Outlook |  Emmanuel Roman, CEO, PIMCO.

© 2017 - Neuhu+